文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

抑癌基因通过 miR-26A1 在非小细胞肺癌中通过增强子重编程被重新激活。

Tumor suppressor genes are reactivated by miR-26A1 via enhancer reprogramming in NSCLC.

机构信息

Department of Oncology, Gansu Provincial Hospital, The First Clinical Medical College of Gansu University of Chinese Medicine, Lanzhou 730000, PR China.

Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai 200000, PR China.

出版信息

Hum Mol Genet. 2023 Jan 1;32(1):79-92. doi: 10.1093/hmg/ddac185.


DOI:10.1093/hmg/ddac185
PMID:35921230
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9838096/
Abstract

Non-small cell lung cancer (NSCLC) is one of the most malignant epithelial tumors. Studies have suggested that DNA hypermethylation of promoters and abnormal histone modifications could induce tumor suppressor genes (TSGs) downregulation in NSCLC. However, the exact mechanism of TSGs downregulation remains unclear. In this study, we found that there is no difference in the regions of most TSGs promoters in NSCLC. Moreover, we found that there is no DNA methylation difference in the region of VILL promoter in NSCLC compared with adjacent tissue samples by pyrosequencing. We further demonstrated that VILL was markedly reactivated in A549 and H1703 cells infected with miR-26A1 lentivirus while this activation was inhibited by JQ1, an enhancer inhibitor. In addition, we identified that miR-26A1 could function as a tumor suppressor to inhibit proliferation and metastasis of NSCLC cells. Chromatin immunoprecipitation assays revealed that overexpression of miR-26A1 could significantly induce the enrichment of H3K27ac at the enhancer regions in A549 cells. To sum up, our findings revealed that enhancer-mediated TSGs regulation occured in NSCLC, suggesting that miR-26A1 could serve as a key regulator and may be a potential therapeutic target for NSCLC.

摘要

非小细胞肺癌(NSCLC)是最恶性的上皮肿瘤之一。研究表明,启动子的 DNA 高甲基化和异常组蛋白修饰可导致 NSCLC 中的肿瘤抑制基因(TSGs)下调。然而,TSGs 下调的确切机制仍不清楚。在本研究中,我们发现 NSCLC 中大多数 TSGs 启动子区域没有差异。此外,我们通过焦磷酸测序发现,与相邻组织样本相比,NSCLC 中 VILL 启动子区域没有 DNA 甲基化差异。我们进一步证明,在感染 miR-26A1 慢病毒的 A549 和 H1703 细胞中,VILL 明显被重新激活,而增强子抑制剂 JQ1 抑制了这种激活。此外,我们发现 miR-26A1 可以作为肿瘤抑制因子抑制 NSCLC 细胞的增殖和转移。染色质免疫沉淀试验显示,miR-26A1 的过表达可显著诱导 A549 细胞增强子区域的 H3K27ac 富集。总之,我们的研究结果揭示了增强子介导的 TSGs 调节在 NSCLC 中发生,表明 miR-26A1 可以作为关键调节剂,并可能成为 NSCLC 的潜在治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a577/9838096/8731ac6fbf14/ddac185f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a577/9838096/c1147cc0c205/ddac185f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a577/9838096/ccbd5c68dd59/ddac185f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a577/9838096/10af4fc56a2c/ddac185f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a577/9838096/b7c5be1def4c/ddac185f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a577/9838096/9406c1fc6b56/ddac185f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a577/9838096/902f4053bb2f/ddac185f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a577/9838096/d5fadaa1d727/ddac185f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a577/9838096/8731ac6fbf14/ddac185f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a577/9838096/c1147cc0c205/ddac185f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a577/9838096/ccbd5c68dd59/ddac185f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a577/9838096/10af4fc56a2c/ddac185f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a577/9838096/b7c5be1def4c/ddac185f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a577/9838096/9406c1fc6b56/ddac185f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a577/9838096/902f4053bb2f/ddac185f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a577/9838096/d5fadaa1d727/ddac185f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a577/9838096/8731ac6fbf14/ddac185f8.jpg

相似文献

[1]
Tumor suppressor genes are reactivated by miR-26A1 via enhancer reprogramming in NSCLC.

Hum Mol Genet. 2023-1-1

[2]
miR-103 Functions as a Tumor Suppressor by Directly Targeting Programmed Cell Death 10 in NSCLC.

Oncol Res. 2017-7-21

[3]
MiroRNA-188 Acts as Tumor Suppressor in Non-Small-Cell Lung Cancer by Targeting MAP3K3.

Mol Pharm. 2018-3-16

[4]
Dysregulated Contributes to the Vitality and Migration of NSCLC Via miR-19a-3p/miR-19b-3p/miR-125b-5p.

DNA Cell Biol. 2022-3

[5]
MicroRNA-379 acts as a tumor suppressor in non-small cell lung cancer by targeting the IGF‑1R-mediated AKT and ERK pathways.

Oncol Rep. 2017-9

[6]
MicroRNA-98 Plays a Suppressive Role in Non-Small Cell Lung Cancer Through Inhibition of SALL4 Protein Expression.

Oncol Res. 2017-7-5

[7]
UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.

Theranostics. 2019-3-17

[8]
MicroRNA-92a promotes growth, metastasis, and chemoresistance in non-small cell lung cancer cells by targeting PTEN.

Tumour Biol. 2016-3

[9]
miR-592 functions as a tumor suppressor in human non-small cell lung cancer by targeting SOX9.

Oncol Rep. 2017-1

[10]
MicroRNA-4465 suppresses tumor proliferation and metastasis in non-small cell lung cancer by directly targeting the oncogene EZH2.

Biomed Pharmacother. 2017-11-21

引用本文的文献

[1]
HBV sequence integrated to enhancer acting as oncogenic driver epigenetically promotes hepatocellular carcinoma development.

J Exp Clin Cancer Res. 2025-5-22

[2]
Easy triplex: An online tool for predicting the formation of DNA-RNA triple helices.

Comput Struct Biotechnol J. 2025-4-9

[3]
Nuclear-activating miRNAs: unveiling the intricacies of subcellular miRNA function and regulation in cancer and immunity disease.

Cancer Cell Int. 2025-4-15

[4]
Epigenetic Modifiers in Cancer Metastasis.

Biomolecules. 2024-7-27

[5]
Nuclear miRNAs as transcriptional regulators in processes related to various cancers (Review).

Int J Oncol. 2024-5

[6]
miR-1246 promotes osteosarcoma cell migration via NamiRNA-enhancer network dependent on Argonaute 2.

MedComm (2020). 2024-4-7

[7]
Exploring the interplay between methylation patterns and non-coding RNAs in non-small cell lung cancer: Implications for pathogenesis and therapeutic targets.

Heliyon. 2024-1-19

本文引用的文献

[1]
Loss of exosomal miR-26a-5p contributes to endometrial cancer lymphangiogenesis and lymphatic metastasis.

Clin Transl Med. 2022-5

[2]
PAX9 reactivation by inhibiting DNA methyltransferase triggers antitumor effect in oral squamous cell carcinoma.

Biochim Biophys Acta Mol Basis Dis. 2022-9-1

[3]
Reactivation of tumour suppressor in breast cancer by enhancer switching through NamiRNA network.

Nucleic Acids Res. 2021-9-7

[4]
Use tumor suppressor genes as biomarkers for diagnosis of non-small cell lung cancer.

Sci Rep. 2021-2-12

[5]
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

CA Cancer J Clin. 2021-5

[6]
Generation of onco-enhancer enhances chromosomal remodeling and accelerates tumorigenesis.

Nucleic Acids Res. 2020-12-2

[7]
Inactivation of tumor suppressor gene Clusterin leads to hyperactivation of TAK1-NF-κB signaling axis in lung cancer cells and denotes a therapeutic opportunity.

Theranostics. 2020

[8]
Targeting of CD38 by the Tumor Suppressor miR-26a Serves as a Novel Potential Therapeutic Agent in Multiple Myeloma.

Cancer Res. 2020-3-19

[9]
Regulatory Mechanism of MicroRNA Expression in Cancer.

Int J Mol Sci. 2020-3-3

[10]
Non-Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment.

Mayo Clin Proc. 2019-8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索